🔗 Share this article Social Media Content Creators Fueling Unofficial Trade for Unapproved Weight-Loss Medication A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations. Investigational Treatment Acquiring Traction Via Social Media The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are urged to message these accounts directly for supplier links, while also obtaining promotional offers. Active Trade on Social Networks Separately, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and claims of next-day British shipping. Sellers promote the substance there before redirecting customers to WhatsApp for transactions. Understanding The Experimental Drug This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic. Medical Experts Express Worries However, doctors and chemists have cautions that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to users injecting products of unknown origin. Some professionals stated the popularity for the experimental drug could be connected to the rising cost of approved weight loss products such as Mounjaro. Legal Position and Implementation Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012. Several content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach medicines, advertising, and consumer regulations, risking fines, prosecution or prison. Platform Reaction and Content Elimination Based on TikTok, the platform has removed problematic content and banned associated keywords and search suggestions. The company said it was committed to keeping the service secure and investing in strengthening compliance measures. Digital Marketplace Operations Investigations also discovered groups with up to 9,000 participants marketing the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, filled with images of slimming results, positive testimonials and detailed instructions for mixing or administering at home. After moments of entering one community, a vendor shared contact information, where the majority of transactions occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about body mass, medical conditions or previous experience. Product Details and Pricing Inside these communities, posts display dark colored parcels with postal service labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.” Buyers can choose between powder vials, prepared at home with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20mg. When asked how long a injector should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”. Platform Oversight and Security Measures A representative for Telegram stated it actively moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”. Medical Professional Cautions “People are administering materials they cannot confirm. Even if the research behind this drug is sound, these digital products may not contain what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service. A medical professional of Asda Online Doctor linked the surge in interest to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said. Her team has previously encountered patients harmed by personal administration from unverified sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.” Producer Statement A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly experimental product not yet authorized … may subject patients to potentially serious health risks”.